Community Health Systems, Inc. (NYSE:CYH) Q4 2022 Earnings Conference Call February 16, 2023 11:00 AM ET

Company Participants

Shelly Schussele - Senior Director, Investor Relations

Tim Hingtgen - Chief Executive Officer

Kevin Hammons - President and Chief Financial Officer

Lynn Simon - President of Clinical Operations and Chief Medical Officer

Conference Call Participants

Josh Raskin - Nephron Research

Kevin Fischbeck - Bank of America

Jason Cassorla - Citi

Stephen Baxter - Wells Fargo

Operator

Good day, and welcome to the Community Health Systems Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded. I would now like to turn the conference over to Ms. Shelly Schussele, Senior Director of Investor Relations. Please go ahead, ma'am.

Shelly Schussele

Thank you, Chuck. Good morning, and welcome to Community Health Systems fourth quarter 2022 Conference Call. Joining me on today's call are Tim Hingtgen, Chief Executive Officer; Kevin Hammons, President and Chief Financial Officer; and Dr. Lynn Simon, President of Clinical Operations and Chief Medical Officer. Before we begin, I would like to remind everyone this conference call may contain certain forward-looking statements including all statements that do not relate solely to historical or current facts.

These forward-looking statements are subject to a number of known and unknown risks, which are described in headings such as Risk Factors in our annual report on Form 10-K and other reports filed with or furnished to the Securities and Exchange Commission. As a consequence, actual results may differ significantly from those expressed in any forward-looking statements in today's discussion.

We do not intend to update any of these forward-looking statements. Yesterday afternoon, we issued a press release with our financial statements and definitions and calculations of adjusted EBITDA and adjusted EPS. We have also posted a supplemental slide presentation on our website.

We will refer to those slides during this call. All calculations we will discuss exclude gain or loss from early extinguishment of debt, impairment expense, as well as gains or losses on the sale of businesses, expense from government and other legal matters and related costs, income or expense from the settlement of professional liability claims for which the third-party insurers obligation to ensure the company for the underlying loss has been settled, expense related to employee termination benefits, and other restructuring charges, gain from CoreTrust transaction, a sale of equity interest in Macon Healthcare LLC, and change in estimate for professional claims liability related to divested locations.